Log in to save to my catalogue

Targeting CYP2J to reduce paclitaxel-induced peripheral neuropathic pain

Targeting CYP2J to reduce paclitaxel-induced peripheral neuropathic pain

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5098623

Targeting CYP2J to reduce paclitaxel-induced peripheral neuropathic pain

About this item

Full title

Targeting CYP2J to reduce paclitaxel-induced peripheral neuropathic pain

Publisher

United States: National Academy of Sciences

Journal title

Proceedings of the National Academy of Sciences - PNAS, 2016-11, Vol.113 (44), p.12544-12549

Language

English

Formats

Publication information

Publisher

United States: National Academy of Sciences

More information

Scope and Contents

Contents

Chemotherapy-induced peripheral neuropathic pain (CIPNP) is a severe dose- and therapy-limiting side effect of widely used cytostatics that is particularly difficult to treat. Here, we report increased expression of the cytochrome-P450-epoxygenase CYP2J6 and increased concentrations of its linoleic acid metabolite 9,10-EpOME (9,10-epoxy-12Z-octadec...

Alternative Titles

Full title

Targeting CYP2J to reduce paclitaxel-induced peripheral neuropathic pain

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5098623

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5098623

Other Identifiers

ISSN

0027-8424

E-ISSN

1091-6490

DOI

10.1073/pnas.1613246113

How to access this item